CenterBook Partners LP acquired a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 15,289 shares of the financial services provider's stock, valued at approximately $2,610,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. BlackRock Inc. bought a new stake in shares of Marsh & McLennan Companies in the 2nd quarter valued at about $6,583,806,000. Corient Private Wealth LP purchased a new stake in shares of Marsh & McLennan Companies in the 2nd quarter worth approximately $66,475,000. Ninety One UK Ltd boosted its stake in shares of Marsh & McLennan Companies by 41.8% during the third quarter. Ninety One UK Ltd now owns 5,632,700 shares of the financial services provider's stock valued at $961,671,000 after purchasing an additional 1,661,178 shares in the last quarter. Deutsche Bank AG purchased a new position in Marsh & McLennan Companies during the second quarter valued at approximately $685,621,000. Finally, Bank of America Corp DE purchased a new position in Marsh & McLennan Companies during the second quarter valued at approximately $575,845,000. 87.99% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of equities analysts recently commented on the stock. UBS Group boosted their price objective on shares of Marsh & McLennan Companies from $216.00 to $222.00 and gave the stock a "buy" rating in a research note on Tuesday, October 6th. Wells Fargo & Company lifted their price target on Marsh & McLennan Companies from $183.00 to $197.00 and gave the company an "equal weight" rating in a report on Friday, October 16th. Erste Group Bank raised Marsh & McLennan Companies to a "strong-buy" rating in a research report on Tuesday, September 8th. BMO Capital Markets upgraded Marsh & McLennan Companies from a "market perform" rating to an "outperform" rating and upped their price objective for the stock from $204.00 to $230.00 in a research note on Tuesday, November 3rd. Finally, Evercore dropped their price objective on Marsh & McLennan Companies from $234.00 to $224.00 in a research report on Thursday, October 8th. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $205.84.
Get Our Latest Analysis on MRSH
Marsh & McLennan Companies Stock Down 0.3%
NYSE MRSH opened at $204.29 on Monday. Marsh & McLennan Companies, Inc. has a 52 week low of $156.60 and a 52 week high of $214.00. The stock's 50 day moving average price is $183.78. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.09 and a current ratio of 1.09. The company has a market cap of $97.14 billion, a price-to-earnings ratio of 24.44, a PEG ratio of 2.77 and a beta of 0.53.
Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last announced its earnings results on Thursday, October 15th. The financial services provider reported $2.03 earnings per share for the quarter, beating the consensus estimate of $1.96 by $0.07. The company had revenue of $6.86 billion during the quarter. Marsh & McLennan Companies had a net margin of 14.20% and a return on equity of 33.32%. The business's revenue for the quarter was up 8.1% compared to the same quarter last year. On average, equities research analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.49 earnings per share for the current fiscal year.
Marsh & McLennan Companies Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Thursday, October 1st will be given a dividend of $0.99 per share. This represents a $3.96 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Thursday, October 1st. Marsh & McLennan Companies's dividend payout ratio is currently 47.37%.
Insider Activity
In other Marsh & McLennan Companies news, CEO Dean Klisura sold 4,194 shares of the stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $200.00, for a total value of $838,800.00. Following the completion of the sale, the chief executive officer directly owned 20,935 shares in the company, valued at approximately $4,187,000. This trade represents a 16.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Stacy Mills sold 1,215 shares of the firm's stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $200.00, for a total value of $243,000.00. Following the completion of the sale, the vice president directly owned 2,705 shares of the company's stock, valued at approximately $541,000. This represents a 30.99% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 0.38% of the company's stock.
Key Marsh & McLennan Companies News
Here are the key news stories impacting Marsh & McLennan Companies this week:
- Positive Sentiment: Zacks Research raised its FY2027 EPS estimate to $11.39 from $11.23 and FY2028 to $12.28 from $12.13. It also nudged several quarterly forecasts higher. These revisions point to improving expectations for earnings growth, though they are one research firm’s estimates.
- Positive Sentiment: BMO Capital Markets raised MRSH to Outperform, a favorable analyst rating that may bolster investor sentiment. Read article: Marsh & McLennan Companies Raised to Outperform at BMO Capital Markets
- Positive Sentiment: A published valuation analysis says MRSH may be 27% undervalued following the AltamarCAM deal, suggesting potential upside if investors agree with its assessment. Read article: Marsh Stock May Be 27% Undervalued Following AltamarCAM Deal
- Neutral Sentiment: Marsh appointed Marcus Baker chairman and Michael Walls global head of Marine, Cargo, and Logistics. The leadership changes may be relevant to the business, but the report provides no financial details indicating an immediate earnings impact. Read article: Marsh & McLennan appoints Marcus Baker and Michael Walls
- Negative Sentiment: Zacks lowered its Q4 2026 EPS estimate to $2.15 from $2.19 and Q3 2027 to $2.19 from $2.21. Its FY2026 estimate of $10.43 also remains below the cited consensus of $10.48, indicating some near-term caution.
Marsh & McLennan Companies Profile
(
Free Report)
Marsh & McLennan Companies, now known as Marsh, is a professional services firm focused on risk, strategy and people. Its businesses help organizations assess and manage risk, arrange insurance and reinsurance, and address workforce and organizational challenges.
The company operates through Marsh, an insurance brokerage and risk advisory business; Guy Carpenter, which specializes in reinsurance and related risk services; Mercer, which provides health, wealth and career consulting; and Oliver Wyman, a management consulting firm.
Featured Stories
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.